2025年生命科学领域人工智慧全球市场报告

预计未来几年，生命科学领域的人工智慧市场将呈指数级增长，到2029年将达到84.2亿美元，复合年增长率为23.7%。预测期内的成长可归因于人们对即时远端患者监护(RPM) 系统日益增长的兴趣、药物研发领域对人工智慧的需求不断增长，以及医学影像分析领域对人工智慧的采用日益增多。预测期内的主要趋势包括策略伙伴关係、产品创新、技术进步、投资和研发。

未来五年23.7%的成长率预测较先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致美国和瑞士开发的人工智慧（AI）主导的基因组定序分析仪和药物交互作用预测平台的价格上涨，阻碍英国生物医学研究，延缓科学突破并增加研发支出。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，贸易摩擦的影响可能更为广泛。

人们对即时远端患者监护(RPM) 系统日益增长的兴趣可能会在短期内推动人工智慧在生命科学市场的扩张。远端患者监护系统采用科技主导的医疗保健解决方案，旨在超越传统医疗环境监控病人健康状况。在生命科学领域，人工智慧在远端患者监护中发挥关键作用，透过提供持续、个人化和数据主导的洞察，促进主动医疗管理。美国数位医疗保健公司 Vivalink 进行的一项调查显示，临床医生对远端患者监护(RPM) 的采用率显着上升，从 2021 年的 20% 增长到 2022 年的 81%，增幅高达 305%。因此，人们对即时远端患者监护(RPM) 系统日益增长的兴趣正在推动生命科学市场人工智慧的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球生命科学人工智慧：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球生命科学人工智慧市场：成长率分析
• 全球生命科学人工智慧市场表现：规模与成长，2019-2024
• 全球生命科学人工智慧市场预测：规模与成长，2024-2029 年，2034 年预测
• 全球生命科学领域的人工智慧：总潜在市场（TAM）

第六章 市场细分

• 全球生命科学领域人工智慧市场：依产品、现况及预测，2019-2024 年、2024-2029 年、2034 年
• 软体
• 硬体
• 服务
• 全球生命科学领域人工智慧市场：部署、表现与预测（2019-2024 年、2024-2029 年及 2034 年）
• 本地部署
• 云端基础
• 全球生命科学领域人工智慧市场：应用、表现与预测（2019-2024 年、2024-2029 年及 2034 年）
• 药物研发
• 医疗诊断
• 生物技术
• 临床试验
• 精准医疗与个人化医疗
• 病患监测
• 全球生命科学人工智慧市场：依软体类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 药物研发软体
• 基因组分析软体
• 临床试验管理软体
• 个人化医疗软体
• 实验室资讯管理系统（LIMS）
• 全球生命科学领域人工智慧市场：按硬体（类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 人工智慧实验室设备
• 机器人和自动化系统
• 影像设备和装置
• 感测器技术
• 全球生命科学领域人工智慧市场：按服务类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 咨询服务
• 数据分析服务
• 研发服务
• 实施和整合服务
• 培训和支援服务

第七章 区域和国家分析

• 全球生命科学人工智慧市场：区域分析、预测与成长，2019-2024 年、2024-2029 年、2034 年
• 全球生命科学领域人工智慧市场：各国发展、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 生命科学领域的人工智慧：竞争格局
• 生命科学市场中的人工智慧：公司简介
  • Google LLC Overview, Products and Services, Strategy and Financial Analysis
  • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Nvidia Corporation
• Novo Nordisk A/S
• Siemens Healthineers AG
• Philips Healthcare
• Babylon Healthcare Services Ltd.
• Komodo Health Inc.
• Modernizing Medicine Inc.
• Viz.ai Inc.
• Butterfly Network Inc.
• Augmedix
• AiCure LLC
• HealthTap Inc.
• Welltok Inc.
• Enlitic Inc.
• PathAI Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年生命科学市场中的人工智慧：提供新机会的国家
• 2029年生命科学市场人工智慧：细分领域带来新机会
• 2029年生命科学市场人工智慧：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Artificial intelligence (AI) in life sciences involves the application of AI technologies and techniques across various domains within the life sciences industry. The integration of AI aims to enhance and expedite processes, improve decision-making, and extract valuable insights from complex data sets.

The primary components of artificial intelligence in life sciences include software, hardware, and services. The software employs AI algorithms to analyze extensive chemical databases, predicting the likelihood of specific molecules binding to target receptors, thereby accelerating the drug discovery process. These software applications can be deployed through on-premises and cloud-based models and find applications in various domains such as drug discovery, medical diagnosis, biotechnology, clinical trials, precision and personalized medicine, and patient monitoring.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The artificial intelligence in life sciences market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in life sciences market statistics, including artificial intelligence in life sciences industry global market size, regional shares, competitors with artificial intelligence in life sciences market share, detailed artificial intelligence in life science market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence in life sciences industry. This artificial intelligence in life sciences market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in life sciences market size has grown exponentially in recent years. It will grow from $2.92 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 23.2%. The growth in the historic period can be attributed to increasing number of clinical trials, increasing adoption of ai in the domain of research and development, high emphasis on the development of precision medicine and personalized drugs.

The artificial intelligence in life sciences market size is expected to see exponential growth in the next few years. It will grow to $8.42 billion in 2029 at a compound annual growth rate (CAGR) of 23.7%. The growth in the forecast period can be attributed to the increasing interest in real-time remote patient monitoring (rpm) systems, increasing demand for AI in drug discovery, the increasing adoption of ai in medical imaging analysis. Major trends in the forecast period include strategic partnership, product innovations, technological advancements, investments, research and developments.

The forecast of 23.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biomedical research by inflating prices of Artificial intelligence(AI)-driven genomic sequencing analyzers and drug interaction prediction platforms developed in the UK and Switzerland, resulting in slower scientific breakthroughs and higher Research and Developemnet (R&D) expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing interest in real-time remote patient monitoring (RPM) systems is set to drive the expansion of artificial intelligence in the life sciences market in the foreseeable future. Remote patient monitoring systems, characterized by technology-driven healthcare solutions, aim to monitor patients' health beyond traditional healthcare settings. In the life sciences domain, AI plays a pivotal role in remote patient monitoring, offering continuous, personalized, and data-driven insights that facilitate proactive healthcare management. A survey conducted by Vivalink, a US-based digital healthcare company, revealed a noteworthy surge in clinicians' adoption of remote patient monitoring (RPM), growing from 20% in 2021 to 81% in 2022, representing a substantial 305% increase. Consequently, the rising interest in real-time remote patient monitoring (RPM) systems is steering the growth of artificial intelligence in the life sciences market.

Leading companies operating in the artificial intelligence in the life sciences market are directing their efforts towards innovative products featuring technological advancements, exemplified by drug discovery software, to maintain their market standing. Drug discovery software comprises computer programs and applications tailored to assist researchers in the pharmaceutical and biotechnology sectors during the drug discovery process. In December 2023, Merck, a Germany-based science and technology company, unveiled AIDDISON, a revolutionary drug discovery software. Positioned as the first of its kind, AIDDISON integrates virtual molecule design with real-world manufacturability, leveraging generative AI, machine learning, and computer-aided drug design. AIDDISON excels in identifying drug candidates from a vast array of possibilities, considering essential properties such as non-toxicity and solubility. Its unique capability to bridge the gap between virtual molecule design and real-world manufacturability underscores a notable application of artificial intelligence in the life sciences sector.

In June 2023, Verix, a US-based company specializing in pharma commercial operations, completed the acquisition of Start-up.AI for an undisclosed sum. Verix's strategic move to acquire Start-up.AI aims to fortify its capabilities in artificial intelligence (AI) and machine learning (ML) within the pharmaceutical commercial operations sector. Start-up.ai, based in Israel, is a provider of an AI-driven commercial optimization platform, enhancing Verix's prowess in life science AI capabilities.

Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.

North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in the life sciences market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial intelligence (AI) in the life sciences market consists of revenues earned by entities by private analytics, AI-driven clinical trial services, and real-world evidence services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the life sciences market also consists of sales of high-performance computing (HPC) clusters, edge computing devices, and IoT devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Life Sciences Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in life sciences market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in life sciences ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in life sciences market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Offering: Software; Hardware; Services
• 2) By Deployment: On-Premises; Cloud-Based
• 3) By Application: Drug Discovery; Medical Diagnosis; Biotechnology; Clinical Trails; Precision And Personalized Medicine; Patient Monitoring
• Subsegments:
• 1) By Software: Drug Discovery Software; Genomic Analysis Software; Clinical Trial Management Software; Personalized Medicine Software; Laboratory Information Management Systems (LIMS)
• 2) By Hardware: AI-Enabled Laboratory Equipment; Robotics And Automation Systems; Imaging Devices And Equipment; Sensor Technologies
• 3) By Services: Consulting Services; Data Analytics Services; Research And Development Services; Implementation And Integration Services; Training And Support Services
• Companies Mentioned: Google LLC; Microsoft Corporation; Intel Corporation; IBM Corporation; Medtronic PLC; Nvidia Corporation; Novo Nordisk A/S; Siemens Healthineers AG; Philips Healthcare; Babylon Healthcare Services Ltd.; Komodo Health Inc.; Modernizing Medicine Inc.; Viz.ai Inc.; Butterfly Network Inc.; Augmedix; AiCure LLC; HealthTap Inc.; Welltok Inc.; Enlitic Inc.; PathAI Inc.; Nano-X Imaging Ltd.; Berg LLC; Insitro; Sense.ly Inc.; Subtle Medical Inc.; Medasense Biometrics Limited; Immunai; Atomwise Inc.; Freenome Holdings Inc.; CloudMedX Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Life Sciences Market Characteristics

3. Artificial Intelligence In Life Sciences Market Trends And Strategies

4. Artificial Intelligence In Life Sciences Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence In Life Sciences Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence In Life Sciences PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence In Life Sciences Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence In Life Sciences Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence In Life Sciences Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence In Life Sciences Total Addressable Market (TAM)

6. Artificial Intelligence In Life Sciences Market Segmentation

• 6.1. Global Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Hardware
• Services
• 6.2. Global Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• On-Premises
• Cloud-Based
• 6.3. Global Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery
• Medical Diagnosis
• Biotechnology
• Clinical Trials
• Precision And Personalized Medicine
• Patient Monitoring
• 6.4. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery Software
• Genomic Analysis Software
• Clinical Trial Management Software
• Personalized Medicine Software
• Laboratory Information Management Systems (LIMS)
• 6.5. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Enabled Laboratory Equipment
• Robotics And Automation Systems
• Imaging Devices And Equipment
• Sensor Technologies
• 6.6. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Data Analytics Services
• Research And Development Services
• Implementation And Integration Services
• Training And Support Services

7. Artificial Intelligence In Life Sciences Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence In Life Sciences Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence In Life Sciences Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Life Sciences Market

• 8.1. Asia-Pacific Artificial Intelligence In Life Sciences Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Life Sciences Market

• 9.1. China Artificial Intelligence In Life Sciences Market Overview
• 9.2. China Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Life Sciences Market

• 10.1. India Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Life Sciences Market

• 11.1. Japan Artificial Intelligence In Life Sciences Market Overview
• 11.2. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Life Sciences Market

• 12.1. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Life Sciences Market

• 13.1. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Life Sciences Market

• 14.1. South Korea Artificial Intelligence In Life Sciences Market Overview
• 14.2. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Life Sciences Market

• 15.1. Western Europe Artificial Intelligence In Life Sciences Market Overview
• 15.2. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Life Sciences Market

• 16.1. UK Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Life Sciences Market

• 17.1. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Life Sciences Market

• 18.1. France Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Life Sciences Market

• 19.1. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Life Sciences Market

• 20.1. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Life Sciences Market

• 21.1. Eastern Europe Artificial Intelligence In Life Sciences Market Overview
• 21.2. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Life Sciences Market

• 22.1. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Life Sciences Market

• 23.1. North America Artificial Intelligence In Life Sciences Market Overview
• 23.2. North America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Life Sciences Market

• 24.1. USA Artificial Intelligence In Life Sciences Market Overview
• 24.2. USA Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Life Sciences Market

• 25.1. Canada Artificial Intelligence In Life Sciences Market Overview
• 25.2. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Life Sciences Market

• 26.1. South America Artificial Intelligence In Life Sciences Market Overview
• 26.2. South America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Life Sciences Market

• 27.1. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Life Sciences Market

• 28.1. Middle East Artificial Intelligence In Life Sciences Market Overview
• 28.2. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Life Sciences Market

• 29.1. Africa Artificial Intelligence In Life Sciences Market Overview
• 29.2. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Life Sciences Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence In Life Sciences Market Competitive Landscape
• 30.2. Artificial Intelligence In Life Sciences Market Company Profiles
  • 30.2.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Life Sciences Market Other Major And Innovative Companies

• 31.1. Nvidia Corporation
• 31.2. Novo Nordisk A/S
• 31.3. Siemens Healthineers AG
• 31.4. Philips Healthcare
• 31.5. Babylon Healthcare Services Ltd.
• 31.6. Komodo Health Inc.
• 31.7. Modernizing Medicine Inc.
• 31.8. Viz.ai Inc.
• 31.9. Butterfly Network Inc.
• 31.10. Augmedix
• 31.11. AiCure LLC
• 31.12. HealthTap Inc.
• 31.13. Welltok Inc.
• 31.14. Enlitic Inc.
• 31.15. PathAI Inc.

32. Global Artificial Intelligence In Life Sciences Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Life Sciences Market

34. Recent Developments In The Artificial Intelligence In Life Sciences Market

35. Artificial Intelligence In Life Sciences Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence In Life Sciences Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence In Life Sciences Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence In Life Sciences Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer